Clinical trial
Gamma Induction for Amyloid Clearance in Alzheimer's Disease
NCT03880240 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gamma Induction for Amyloid Clearance in Alzheimer's Disease
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 5, 2019
- Completion date
- November 30, 2024
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, mild cognitive impairment